TLDR
- GEVI will uplist from OTC to the NYSE American on December 4, 2025.
- Shares will trade under the new ticker symbol CITR.
- The CEO says the listing strengthens liquidity and broadens investor reach.
- GEVI delivered a 2,548% five-year return, far outpacing the S&P 500.
- The move highlights rising demand for CitroTech wildfire prevention solutions.
General Enterprise Ventures, Inc. (GEVI) is set to reach a transformative milestone as the stock trades at $7.15 at market close, with the company announcing approval to uplist to the NYSE American.
General Enterprise Ventures, Inc., GEVI
Public trading under the new ticker CITR will begin at the opening bell on December 4, 2025, marking a pivotal advancement for the company’s market presence. GEVI has not yet announced its next earnings date, but the timing of the uplisting aligns with the company’s expanding commercial and strategic initiatives.
The transition reflects significant progress for the business and its core CitroTech product family, which targets wildfire prevention, wood treatment, and asset protection. As the company shifts from the OTC market to a national exchange, investors gain access to improved liquidity and broader institutional visibility.
Strategic Advantages of the NYSE American Listing
CEO Wes Bolsen described the uplisting as a validation of the company’s business model and the growing demand for sustainable protection technologies. He emphasized that the move strengthens GEVI’s ability to reach a larger investor base while supporting long-term value creation. The decision also elevates corporate credibility at a time when wildfire risks across North America continue to increase.
The company stated that no shareholder action is required. Trading on the OTC market will continue until the close of business on December 3, 2025, at which point the transition to the NYSE American becomes effective. The upgrade introduces GEVI to more analysts, institutional participants, and index-tracking investment vehicles.
Market Momentum and Long-Term Returns
GEVI’s performance metrics reveal powerful multi-year growth. As of 11/28/2025, the stock delivered a 63.29% YTD return, far surpassing the S&P 500’s 16.45% gain. Its 1-year return of 39.38% continues to show strength relative to broader markets.
The growth becomes more pronounced across longer periods. GEVI generated a 231.02% return over three years, compared with the S&P 500’s 72.78%. The most striking data point is the five-year return of 2,548.16%, positioning GEVI among the highest-performing micro-cap growth stories in the OTC ecosystem. Such momentum underscores investor belief in the commercialization potential of the CitroTech product line.
CitroTech Demand Strengthens the Uplisting Narrative
The CitroTech family includes chemical formulations designed for wildfire mitigation and wood product reinforcement. With wildfire seasons intensifying globally, government agencies, industrial clients, and property managers have shown rising interest in preventive treatment solutions. GEVI’s ability to meet that demand has strengthened the case for a national exchange listing.
CEO Wes Bolsen highlighted that the company’s expansion into prevention and asset protection platforms reflects a sustainable revenue strategy. The uplisting enhances GEVI’s ability to pursue commercial contracts, broaden distribution, and expand manufacturing capabilities.
Growing Investor Access and a More Competitive Position
By moving to the NYSE American, GEVI positions itself in a competitive environment where liquidity, governance standards, and analyst coverage improve meaningfully. The transition also aligns with investor expectations for transparency, compliance, and scale readiness. GEVI’s leadership views the uplisting as a strategic step toward deeper institutional engagement and long-term shareholder value.
The company’s multi-year growth trajectory, combined with the national exchange listing, places GEVI in a stronger position to capitalize on future opportunities while accelerating product adoption across key markets.


